nattydisaster
PESCIENCE.com
- Awards
- 3
Someone go take 4 scoops of High Volume and report back if your pumps are superhuman like
[h=1]L-citrulline Improves Splanchnic Perfusion and Reduces Gut Injury during Exercise.[/h]
[h=3]Abstract[/h][h=4]PURPOSE:[/h]Splanchnic hypoperfusion is a physiological phenomenon during strenuous exercise. It has been associated with gastrointestinal symptoms, intestinal injury, and may hamper athletic performance. We hypothesized that L-citrulline supplementation improves splanchnic perfusion and decreases intestinal injury by enhancing arginine availability. The aim of this study was to determine the effect of L-citrulline intake on splanchnic perfusion, intestinal injury and barrier function during exercise.
[h=4]METHODS:[/h]In this randomized, double-blinded crossover study, ten men cycled for 60 min at 70% of their maximum workload after L-citrulline (10 g) or placebo (L-alanine) intake. Splanchnic perfusion was assessed using gastric air tonometry. Sublingual microcirculation was evaluated by sidestream dark-field imaging. Plasma amino acid levels and intestinal fatty-acid binding protein (I-FABP) concentrations, reflecting enterocyte damage, were assessed every 10 min. Urinary excretion of sugar probes was measured to evaluate intestinal permeability changes.
[h=4]RESULTS:[/h]Oral L-citrulline supplementation enhanced plasma citrulline (1840.3±142.3 μM) and arginine levels (238.5±9.1 μM) compared to placebo (45.7±4.8 μM and 101.5±6.1 μM, respectively; P<0.0001), resulting in increased arginine availability. Splanchnic hypoperfusion was prevented during exercise following L-citrulline ingestion (reflected by unaltered gapg-apCO2 levels), whereas gapg-apCO2 increased with placebo treatment (P<0.01). Accordingly, L-citrulline intake resulted in an increased number of perfused small sublingual vessels compared with placebo (7.8±6.0 vs. -2.0±2.4; P=0.06). Furthermore, plasma I-FABP levels were attenuated during exercise following L-citrulline supplementation compared to placebo (AUC0-60min -185±506 vs. 1318±553 %; P<0.01). No significant differences were observed for intestinal permeability.
[h=4]CONCLUSION:[/h]Pre-exercise L-citrulline intake preserves splanchnic perfusion and attenuates intestinal injury during exercise in athletes compared to placebo, probably by enhancing arginine availability. These results suggest that oral L-citrulline supplementation is a promising intervention to combat splanchnic hypoperfusion-induced intestinal compromise.
[h=1]L-citrulline Improves Splanchnic Perfusion and Reduces Gut Injury during Exercise.[/h]
[h=3]Abstract[/h][h=4]PURPOSE:[/h]Splanchnic hypoperfusion is a physiological phenomenon during strenuous exercise. It has been associated with gastrointestinal symptoms, intestinal injury, and may hamper athletic performance. We hypothesized that L-citrulline supplementation improves splanchnic perfusion and decreases intestinal injury by enhancing arginine availability. The aim of this study was to determine the effect of L-citrulline intake on splanchnic perfusion, intestinal injury and barrier function during exercise.
[h=4]METHODS:[/h]In this randomized, double-blinded crossover study, ten men cycled for 60 min at 70% of their maximum workload after L-citrulline (10 g) or placebo (L-alanine) intake. Splanchnic perfusion was assessed using gastric air tonometry. Sublingual microcirculation was evaluated by sidestream dark-field imaging. Plasma amino acid levels and intestinal fatty-acid binding protein (I-FABP) concentrations, reflecting enterocyte damage, were assessed every 10 min. Urinary excretion of sugar probes was measured to evaluate intestinal permeability changes.
[h=4]RESULTS:[/h]Oral L-citrulline supplementation enhanced plasma citrulline (1840.3±142.3 μM) and arginine levels (238.5±9.1 μM) compared to placebo (45.7±4.8 μM and 101.5±6.1 μM, respectively; P<0.0001), resulting in increased arginine availability. Splanchnic hypoperfusion was prevented during exercise following L-citrulline ingestion (reflected by unaltered gapg-apCO2 levels), whereas gapg-apCO2 increased with placebo treatment (P<0.01). Accordingly, L-citrulline intake resulted in an increased number of perfused small sublingual vessels compared with placebo (7.8±6.0 vs. -2.0±2.4; P=0.06). Furthermore, plasma I-FABP levels were attenuated during exercise following L-citrulline supplementation compared to placebo (AUC0-60min -185±506 vs. 1318±553 %; P<0.01). No significant differences were observed for intestinal permeability.
[h=4]CONCLUSION:[/h]Pre-exercise L-citrulline intake preserves splanchnic perfusion and attenuates intestinal injury during exercise in athletes compared to placebo, probably by enhancing arginine availability. These results suggest that oral L-citrulline supplementation is a promising intervention to combat splanchnic hypoperfusion-induced intestinal compromise.
